Projects Pharmaceuticals

Administration Agency for the Chemotherapy Compounding Payments Scheme (CCPS)

Projects Pharmaceuticals

Administration Agency for the Chemotherapy Compounding Payments Scheme (CCPS)

Projects Pharmaceuticals

Administration Agency for the Chemotherapy Compounding Payments Scheme (CCPS)

  • Services

    Program Administration

  • Status

    Current

  • Client

    Commonwealth Department of Health

  • Jurisdiction

    Australia

The Chemotherapy Compounding Payments Scheme (CCPS) ensures that all Australians who require chemotherapy have access to these anti-cancer drugs.

AHA manages the scheme on behalf of the Department, operating as the CCPS Administration Agency.

Chemotherapy medicine infusions are more complex to dispense than standard medicines because:

  • Many are highly toxic
  • Doses vary according to patient size or treatment requirement
  • Doses must usually be compounded in sterile conditions shortly before the infusion is administered.

Compounders registered under the CCPS receive a fee for each PBS dose compounded into a chemotherapy infusion.

AHA developed a customised online system to streamline claims processing. We also host the CCPS website and provide support and advice about the scheme via telephone and e-mail help-desk.

Each year, we disburse around $15 million of funds to TGA-licensed compounders under the scheme. Our processes are underpinned by rigorous compliance monitoring and regular reports to the Department.

Chemotherapy is the use of cytotoxic drugs to destroy cancerous and malignant cells.